Loading data
INSGNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 166.19 m USD | 191.24 m USD | 167.29 m USD | 245.32 m USD | 262.4 m USD |
| Cost of revenue | — | — | — | 178.41 m USD | 186.47 m USD |
| Gross profit | 71 m USD | 68.8 m USD | 35.78 m USD | 66.91 m USD | 75.93 m USD |
| Research and development expense | 19.8 m USD | 20.6 m USD | 19.73 m USD | 38.29 m USD | 52.67 m USD |
| Operating profit | 4.32 m USD | 1.72 m USD | -35.96 m USD | -57.92 m USD | -46.52 m USD |
| Profit before tax | 1.28 m USD | -13.68 m USD | -44.97 m USD | -68.43 m USD | -47.72 m USD |
| Income tax expense | 44 k USD | 689 k USD | 43 k USD | -465 k USD | 191 k USD |
| Net income (reported basis) | 838 k USD | 4.57 m USD | -46.19 m USD | -67.97 k USD | -48.13 m USD |
| Net income attributable to common shareholders | -2.74 m USD | 1.3 m USD | -49.18 m USD | -70.71 m USD | -52.37 m USD |
| Basic earnings per share | -0.18 USD/share | 0.1 USD/share | -4.32 USD/share | -6.59 USD/share | -0.51 USD/share |
| Diluted earnings per share | -0.18 USD/share | 0.1 USD/share | -4.32 USD/share | -6.59 USD/share | -0.51 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.